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A bstract
Th is  s tu dy  w as  con ducted  to  de term in e if an  
o ra l squam ou s ce ll carc in om a a lters  m R N A  ex-
p ress io n  o f sero ton in  transpo rter (5 -H TT) in  the  
cen tra l nervous  system . K B  ce ll line  d erived  
from  a hum an oral squam ous cell carcinom a w as  
ino cu lated  in to  nu de  m ice , an d  m R N A  expres -
s ion  leve l o f 5 -H TT  in  the  dorsa l raphe  nucleus 
(D R N ) w as  exam ined  by  in  s itu  hybrid iza tio n  
w hen the tum or m ass reached to  -10%  of to tal 
body w eight. Plasm a leptin  levels w ere determ in -
ed by radio im m unoassay m ethod using a com -
m ercial kit. 5-H TT m R N A  level w as significantly  
decreased in  the  D R N  o f tu m or bearing  m ice , 
com pared to  the age-m atching non-tum or con -
tro l. P lasm a leptin  level decreased concom itantly  
in tum or bearing m ice. These results suggest that 
oral carcinom a m ay suppress 5-HTT gene expres -
sion in  the central nervous system , perhaps in  
relation w ith decreased p lasm a leptin  level.
Keyw ords: depression; gene expression; in situ hy-
bridization; leptin; serotonin; tumor
In troduction
Dysregulation of serotonin (5-hydroxytryptamine, 5- 
HT) system is known to play a role in the patho-
physiology of depressive disorders (Maes and Melt-
zer, 1995; Mann, 1999). It has been reported that 
serum concentrations of tryptophan, 5-HT precursor, 
are significantly decreased in cancer patients (Brown 
et al., 1989; 1991), and that this decrease correlates 
with depressive symptoms in cancer patients under-
going cytokine therapy (Capuron et al., 2002). De-
pression is one of the major symptoms commonly 
found in cancer patients, and reported to worsen sur-
vival of the patients (Goodwin et al., 2004; Klin-
kenberg et al., 2004). However, the mechanism by 
which cancer induces depression in the patients is 
largely unknown.
  5-HT reuptake transporter (5-HTT) is a member of 
the Na+/Cl--dependent membrane transporters family, 
controls the propagation of serotonergic signal timely 
by reuptake of 5-HT from the synaptic cleft immedi-
ately after its release. Pharmacologic inhibition of 
5-HTT with selective 5-HT reuptake inhibitors, such 
as fluoxetine, enhances serotonergic transmission and 
decreases depression symptoms (Gorman and Kent, 
1999). Gene expression of 5-HTT in the dorsal raphe 
nucleus (DRN), where the largest population of sero-
tonergic neurons is located, alters by brain 5-HT level 
(Linnet et al., 1995; Choi et al., 2003). Decreased 
expression or lack of 5-HTT appears to correlate with 
the development of behavioral depression. That is, 
5-HTT mRNA expression was decreased in the DRN 
of ob/ob mouse showing symptoms of behavioral 
depression (Collin et al., 2000), and the number of 
5-HTergic neurons and their neuronal activity was 
decreased in the DRN of 5-HTT knockout mouse 
exhibiting behavioral depression (Lira et al., 2003). 
  5-HTT mRNA level in the DRN has been sug-
gested to correlate with plasma leptin level (Jahng et 
al., 1998; Collin et al., 2000; Johansen et al., 2000). 
It has been reported that leptin increases brain 5-HT 
levels in wild-type and ob/ob mice (Harris et al., 1998; 
Calapai et al., 1999), and that leptin receptors are 
localized in 5-HT or 5-HTT containing neurons in the 
DRN (Collin et al., 2000; Finn et al., 2001; Hay- 
Schmidt et al., 2001). In this study, the DRN ex-
pression of 5-HTT mRNA and the plasma leptin level 
were examined in the mice bearing an oral squamous 
cell carcinoma, in order to define the molecular me-
chanism of the pathogenesis of depression in cancer 
subjects.
M ateria ls and M ethods
Anim als
BALB/c strain male mice at 8 weeks of age were 
purchased (KRIBB, Taejeon, Korea) and maintained 
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in a consistent environment with a 12 h / 12 h light- 
dark cycle (light between 07:00 and 19:00). Mice 
received free access to standard laboratory food 
(Purina Rodent Chow, Purina Co., Seoul, Korea) and 
water (membrane filtered purified water) ad libitum , 
and were cared according to The Guide for Animal 
Experiments, 2000, edited by The Korean Academy 
of Medical Sciences, which is consistent with NIH 
Guideline for the Care and Use of Laboratory Ani-
mals, 1996 revised.
Tum or inoculation
KB cell line, which was derived from a poorly dif-
ferentiated squamous cell carcinoma in the mouth 
floor of 54-year-old man, was prepared at a 5×107 
cells/ml concentration. One ml of the KB cell culture 
was subcutaneously inoculated into the dorsal area 
of mice. The non-tumor control group received 1 ml 
of saline instead. Tumor weight in grams was esti-
mated by an empirically-derived formula: length×
width×1.33/100 (McCarthy and Daun, 1993). Tumor 
masses were excised at sacrifice, weighed and then 
processed for H/E staining to validate the tumor de-
velopment in each animal (data not shown).
In  situ  hybrid ization
Tumor bearing mice were sacrificed for 5-HTT in situ 
hybridization when the tumor mass reached to -10% 
of total body weight (n = 6). Age-matching non-tumor 
mice were processed parallel as the control groups 
(n = 6). Mice were overdosed with sodium pento-
barbital (Hallym Pharmaceutical Co., Seoul, Korea) 
and transcardially perfused first with 100 ml of he-
parinized isotonic saline containing 0.5% NaNO2 
(Sigma Co., Saint Louis, MO), followed by 100 ml of 
ice-cold 4% paraformaldehyde (Sigma Co.) in 0.1 M 
sodium phosphate buffer. Brains were immediately 
removed, post-fixed for 2 h, and transferred into 30% 
sucrose (Sigma Co.) for cryoprotection. Forty micron 
coronal sections were cut on a freezing, sliding mi-
crotome (HM440E, Microm Co., Germany). Alternate 
sections through the rostral-caudal extent of the raphe 
nucleus (between bregma -7.64 and -8.80 mm; 
Paxinos and Watson, 1986) were collected into 20 ml 
glass scintillation vials containing ice-cold 2×SSC 
(0.3 M NaCl, 0.03 M Na Citrate). in situ hybridization 
was performed with 5-HTT cDNA probe (a 0.8 kb 
EcoR1 restriction fragment; Jahng et al., 1998) as 
previously described (Choi et al., 2003).
Plasm a leptin  level
Cardiac blood (n = 12) was collected into the micro-
tubes containing 20 ml of heparin, rapidly after ex-
posing the heart with an overdose of sodium pento-
barbital, and centrifuged at 2,000 rpm for 20 min to 
separate the plasma. The plasma leptin level was 
determined by radioimmunoassay method using a 
commercial kit (Mediagnost mouse/leptin kit, Aspen-
haustr, Reutlingen, Germany).
Im age analysis and statistics
Images on the autoradiographic films were digitized 
with a Zeiss Stemi-2000 stereoscope attached to a 
Dage-MTI CCD 72 camera and MCID image analysis 
system (MCID, Imaging Research Inc., Ontario, Cana-
da). Messenger RNA expression level was determined 
by quantifying the mean relative optical density of 
pixels with densities of at least 2 S.D. above the 
mean density of the image background (mRNA pi-
xels). For each section, the mean background value 
was subtracted from the mean mRNA pixel value. The 
mRNA pixel values were averaged across 5 sections 
from each individual mouse and the average mRNA 
value of each mouse then averaged across all mice 
within each group. The average mRNA value of the 
tumor group was then converted to relative value to 
the control group. All data were analyzed by unpaired 
t-test using StatView software (Abacus, Berkeley, CA).
R esu lts and D iscuss ion
5-HTT expression
Tumor mice were sacrificed when the tumor mass 
reached to -10% of total body weight, the raphe 
nucleus sections of brain tissues were processed for 
in situ hybridization with 5-HTT cDNA probes. 5-HTT 
in situ signals on the autoradiographic films of tumor 
mice appeared to be decreased compared with the 
age-matching non-tumor mice (Figure 1A). Quantifi-
cational analysis of the in situ signals showed a 
significant (P ＜ 0.05) reduction in 5-HTT mRNA ex-
pression level in tumor mice, i.e. -65% of non-tumor 
mice (Figure 1B). It has been reported that gene 
expression level of 5-HTT in the DRN may positively 
correlate with the brain 5-HT level (Linnet et al., 1995; 
Choi et al., 2003), and that the transgenic mouse 
lacking 5-HTT expression exhibits decreases in the 
activity and number of serotonergic neurons in the 
DRN (Lira et al., 2003). These reports together with 
our result suggest that the brain 5-HT system may 
be down-regulated in the tumor bearing mouse. Dy-
sregulation in the brain 5-HT system is known to play 
a role in the pathophysiology of depressive disorders 
(Maes and Meltzer, 1995; Mann, 1999). Indeed, both 
obese (ob/ob) mouse, which exhibits decreased ex-
pression of 5-HTT in the DRN, and 5-HTT knockout 
mouse present behavioral depression (Collin et al., 
2000; Lira et al., 2003). These reports support the 
idea that this tumor animal model may present be-
havioral depression. Depression is one of the major 
symptoms commonly found in cancer patients, and re-
ported to worsen survival of the patients (Goodwin et 
al., 2004; Klinkenberg et al., 2004). However, the 
brain mechanism by which cancer induces depression 
in the patients is not known. Further studies on the 
analyses of brain 5-HT level and behavioral depres-
sion in this animal model will provide valuable in-
formation about the pathogenesis of depression in 
cancer patients.
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Plasm a leptin  and 5-HTT expression
Plasma leptin levels were analyzed when the tumor 
ratio reached to -10% of total body weight. The 
plasma leptin levels of tumor mice were markedly 
decreased (P ＜ 0.05) compared with the age-match-
ing non-tumor mice (Figure 2B), concomitantly with 
the decrease of 5-HTT mRNA level in the DRN. This 
result concurs with previous reports that 5-HTT mRNA 
expression is decreased in ob/ob mouse lacking 
functional leptin (Collin et al., 2000) and in anorexia 
(anx/anx) mouse exhibiting decreased level of the 
plasma leptin (Jahng et al., 1998; Johansen et al., 
2000). Leptin increases brain 5-HT levels in wild-type 
and ob/ob mice (Harris et al., 1998; Calapai et al., 
1999) and 5-HT turnover in the brain of wild-type 
mouse (Calapai et al., 1999). Leptin receptors are 
localized in the 5-HT (Finn et al., 2001; Hay-Schmidt 
et al., 2001) or 5-HTT (Collin et al., 2000) containing 
neurons of the DRN where the most of 5-HT neurons 
are located in the brain. Leptin which was admini-
strated into the lateral ventricle is accumulated in se-
rotonergic neurons of the raphe nucleus (Fernandez- 
Galaz et al., 2002). Leptin-induced hypophagia, a 
major behavioral effect of leptin, is inhibited by sero-
tonergic agents, which suppress the brain 5-HT sys-
tem (Yamada et al., 2003). These reports all suggest 
that plasma leptin may activate the brain 5-HT 
system, perhaps through its stimulatory effect on the 
5-HT and/or 5-HTT neurons in the DRN. Together 
with our result, it is suggested that decreased ex-
pression of 5-HTT in the DRN of this tumor mouse 
may be, at least partly, due to a decrease in the 
plasma leptin level.
Body w eight and plasm a leptin
Initial body weight of tumor mice at tumor inoculation 
did not differ from non-tumor mice (24.817±0.359 g 
vs. 25.440±0.432 g). Real body weight was cal-
culated by subtracting the tumor weight from total 
body weight at sacrifice. Real body weight of tumor 
mice did not significantly differ from the age-matching 
F ig u re  1 . 5-HTT in situ  hybridization in the dorsal raphe nucleus
(DRN) of mouse bearing a human oral squamous cell carcinoma (T)
and the age matching non-tumor control (NT). M ice were sacrificed
for in situ hybridization when the tumor mass reached to -10% of total
body weight. (A) Autoradiography of in situ  signals on X-ray films.
(B) Relative optical density (R.O.D.) of the in situ  signals. 5-HTT
mRNA expression was significantly decreased in the DRN of tumor
mice, compared to the non-tumor controls. a; acquiduct, *P ＜ 0.05
vs. non-tumor control.
F ig u re  2 . Body weight (A) and plasma leptin level (B). Tumor m ice
were sacrificed for the plasma leptin assay when the tumor ratio
reached to -10% of total body weight. Real body weight of the tumor
mice (T), which the tumor weight was subtracted from total body
weight, was not significantly reduced compared with the non-tumor
controls (NT), however, the plasma leptin levels of tumor m ice
significantly decreased. *P ＜ 0.05 vs. non-tumor control.
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non-tumor mice (Figure 2A). Circulating levels of 
leptin, a peptide hormone synthesized in adipose tis-
sue, are positively correlated to the body mass index 
(Maffei et al., 1995). For an example, decreased 
plasma level of leptin in anorexia mutant (anx/anx) 
correlates with a significant weight loss compared with 
its wild type littermates (Jahng et al., 1998). However, 
in this study the plasma leptin level was significantly 
decreased in the tumor bearing mouse despite no 
significant decrease in body weight, compared to the 
non-tumor control. Leptin release is reported to be 
regulated by several factors, such as glucocorticoids 
or insulin stimulates, but catecholamine inhibits its 
release (Fruhbeck et al., 1998). Further study is re-
quired to determine what caused a reduction in 
plasma leptin level in this tumor mouse model.
  In summary, 5-HTT expression was decreased in 
the DRN of mouse bearing a human oral squamous 
cell carcinoma. This decrease may correlate with a 
reduction in the plasma leptin level in this mouse 
model. This is the first report demonstrating that oral 
carcinoma may decrease 5-HTT gene expression in 
the central nervous system. This animal model can 
be used for future studies on the pathogenesis of 
depression in cancer subjects.
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